Neuropace INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

5 Mar 2025

NPCE

10-K: NeuroPace Reports Continued Revenue Growth in 2024, Focuses on Expanded Indications

NeuroPace's 2024 10-K filing highlights revenue growth driven by increased RNS System sales and strategic initiatives, while outlining ongoing efforts to expand market reach and address key risk factors.

NASDAQ

5 Mar 2024

NPCE

Neuropace INC

10-K: NeuroPace, Inc. Outlines Share Structure and Regulatory Compliance in 10-K Filing

NeuroPace, Inc.'s 10-K filing details the company's common stock structure, voting rights, dividend policies, and anti-takeover provisions, alongside a comprehensive overview of its business, risk factors, and regulatory landscape.